Literature DB >> 10792468

Blockade of cadherin-6B activity perturbs the distribution of PSD-95 family proteins in retinal neurones.

Y Honjo1, S Nakagawa, M Takeichi.   

Abstract

BACKGROUND: Synaptic junctions have cadherin-catenin complexes, but their functions are poorly understood. Using retinal neurones, we investigated the role of this adhesion machinery in synaptic organization.
RESULTS: In cultures of chicken retinal cells, cadherin-6B (cad6B) and cadherin-7 (cad7) are expressed by distinct neurones, each being distributed in a punctate pattern along their neurites as well as in the soma. Double-immunostaining for cad6B and PSD-95/SAP90 or other PSD-95 family members, known to localize in the postsynaptic density, showed that their distributions overlapped each other. To assess the role for cad6B, we incubated retinal cells with antibodies that could specifically block cad6B-mediated adhesion. In the antibody-treated neurones, the localization pattern of PSD-95 family proteins was altered, that is, their staining signals tended to be reduced or disarranged. We then examined whether cadherins interacted molecularly with PSD-95: Cadherin immunoprecipitates from brain lysates did not contain PSD-95; nevertheless, this protein was co-precipitated with alphaN- and beta-catenins. When PSD-95 proteins were ectopically expressed in epithelial cells, some of these molecules were concentrated in cell-cell junctions, co-localizing with E-cadherin, and this junctional localization of PSD-95 was abolished by blocking of E-cadherin activity.
CONCLUSION: These results suggest that cadherins play a role in the subcellular organization of postsynaptic density components through some, perhaps indirect, molecular interactions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10792468     DOI: 10.1046/j.1365-2443.2000.00327.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  7 in total

1.  Role of beta-catenin in synaptic vesicle localization and presynaptic assembly.

Authors:  Shernaz X Bamji; Kazuhiro Shimazu; Nikole Kimes; Joerg Huelsken; Walter Birchmeier; Bai Lu; Louis F Reichardt
Journal:  Neuron       Date:  2003-11-13       Impact factor: 17.173

2.  N-cadherin regulates molecular organization of excitatory and inhibitory synaptic circuits in adult hippocampus in vivo.

Authors:  Deanna L Benson; George W Huntley; Jessica S Nikitczuk; Shekhar B Patil; Bridget A Matikainen-Ankney; Joseph Scarpa; Matthew L Shapiro
Journal:  Hippocampus       Date:  2014-04-29       Impact factor: 3.899

3.  ErbB1 receptor ligands attenuate the expression of synaptic scaffolding proteins, GRIP1 and SAP97, in developing neocortex.

Authors:  D Yokomaku; H Jourdi; A Kakita; T Nagano; H Takahashi; N Takei; H Nawa
Journal:  Neuroscience       Date:  2005-10-14       Impact factor: 3.590

4.  Neuronal nicotinic synapse assembly requires the adenomatous polyposis coli tumor suppressor protein.

Authors:  Murali Krishna Temburni; Madelaine M Rosenberg; Narendra Pathak; Russell McConnell; Michele H Jacob
Journal:  J Neurosci       Date:  2004-07-28       Impact factor: 6.167

5.  Urokinase-Type Plasminogen Activator Protects Cerebral Cortical Neurons from Soluble Aβ-Induced Synaptic Damage.

Authors:  Ariel Diaz; Paola Merino; Ji-Dong Guo; Manuel A Yepes; Patrick McCann; Tapasya Katta; Elise M Tong; Enrique Torre; Srikant Rangaraju; Manuel Yepes
Journal:  J Neurosci       Date:  2020-04-24       Impact factor: 6.167

6.  Urokinase-type plasminogen activator promotes N-cadherin-mediated synaptic recovery in the ischemic brain.

Authors:  Ariel Diaz; Paola Merino; Patrick McCann; Manuel A Yepes; Laura G Quiceno; Enrique Torre; Amelia Tomkins; Xiaodong Zhang; Chadwick M Hales; Frank C Tong; Manuel Yepes
Journal:  J Cereb Blood Flow Metab       Date:  2021-03-24       Impact factor: 6.200

7.  Pharmacology of cell adhesion molecules of the nervous system.

Authors:  Darya Kiryushko; Elisabeth Bock; Vladimir Berezin
Journal:  Curr Neuropharmacol       Date:  2007-12       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.